CDKN1B Polyclonal Antibody, PE-Cy7 Conjugated
Referentie bs-0742R-PE-Cy7
Formaat : 100ul
Merk : Bioss
CDKN1B Polyclonal Antibody, PE-Cy7 Conjugated
Applications
Reactivity
Predicted Reactivity
Overview | |
Catalog # | bs-0742r-pe-cy7-100ul |
Product Name | CDKN1B Polyclonal Antibody, PE-Cy7 Conjugated |
Applications | WB, FCM |
Reactivity | Human, Mouse, Rat, Chicken, Others |
Predicted Reactivity | Dog, Sheep, Pig |
Specifications | |
Conjugation | PE-Cy7 |
Host | Rabbit |
Source | KLH conjugated synthetic peptide derived from human CDKN1B |
Immunogen Range | 101-198/198 |
Clonality | Polyclonal |
Isotype | IgG |
Concentration | 1ug/ul |
Purification | Purified by Protein A. |
Storage Buffer | Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
Storage Condition | Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
Target | |
Gene ID | 1027 |
Swiss Prot | P46527 |
Subcellular location | Cytoplasm, Nucleus |
Synonyms | KIP1; MEN4; CDKN4; MEN1B; P27KIP1; Cyclin-dependent kinase inhibitor 1B; Cyclin-dependent kinase inhibitor p27; CDKN1B |
Background | Important regulator of cell cycle progression. Involved in G1 arrest. Potent inhibitor of cyclin E- and cyclin A-CDK2 complexes. Forms a complex with cyclin type D-CDK4 complexes and is involved in the assembly, stability, and modulation of CCND1-CDK4 complex activation. Acts either as an inhibitor or an activator of cyclin type D-CDK4 complexes depending on its phosphorylation state and/or stoichometry. |
Application Dilution | |
WB | 1:300-5000 |
FCM | 1:20-100 |